SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-23-267306
Filing Date
2023-10-31
Accepted
2023-10-31 17:10:00
Documents
16
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A d566770d20fa.htm   iXBRL 20-F/A 77161
2 EX-12.1 d566770dex121.htm EX-12.1 4288
3 EX-12.2 d566770dex122.htm EX-12.2 4246
  Complete submission text file 0001193125-23-267306.txt   328028

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA clls-20221231.xsd EX-101.SCH 5020
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clls-20221231_cal.xml EX-101.CAL 677
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clls-20221231_def.xml EX-101.DEF 21009
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE clls-20221231_lab.xml EX-101.LAB 29276
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clls-20221231_pre.xml EX-101.PRE 22244
10 EXTRACTED XBRL INSTANCE DOCUMENT d566770d20fa_htm.xml XML 9328
Mailing Address 8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE I0 75013
Business Address 8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE I0 75013 33181691600
Cellectis S.A. (Filer) CIK: 0001627281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-36891 | Film No.: 231365623
SIC: 2836 Biological Products, (No Diagnostic Substances)